Samantha L. Gadd, Ph.D.
Affiliations: | 2001 | West Virginia University, Morgantown, WV, United States |
Area:
Biochemistry, Cell Biology, OncologyGoogle:
"Samantha Gadd"Mean distance: 13.53
Parents
Sign in to add mentor| Michael R. Miller | grad student | 2001 | West Virginia University | |
| (Acetaminophen-induced proliferation of estrogen -responsive breast cancer cells is associated with increased c-myc RNA expression and NF-kB activity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gadd S, Huff V, Skol AD, et al. (2022) Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study. Cell Reports. Medicine. 100644 |
| Tomita Y, Shimazu Y, Somasundaram A, et al. (2022) A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M. Glia |
| Dhar S, Gadd S, Patel P, et al. (2022) A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis. Acta Neuropathologica Communications. 10: 47 |
| Ortiz MV, Ahmed S, Burns M, et al. (2019) Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor. Jci Insight. 4 |
| Hoeman CM, Cordero FJ, Hu G, et al. (2019) ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis. Nature Communications. 10: 1023 |
| Armstrong AE, Gadd S, Huff V, et al. (2018) A unique subset of low-risk wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A children’s oncology group study Plos One. 13: 208936 |
| Bailey AW, Suri A, Chou PM, et al. (2018) Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB). Bioengineering (Basel, Switzerland). 5 |
| Gadd S, Huff V, Walz AL, et al. (2017) A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor. Nature Genetics |
| Ortiz MV, Burns M, Eisenberg A, et al. (2017) Abstract 708: Prohibitin is a prognostic marker of treatment failure and therapeutic target to block chemotherapy resistance in Wilms tumor Cancer Research. 77: 708-708 |
| Marsden L, Jennings LJ, Gadd S, et al. (2016) BRAF Exon 15 Mutations in Pediatric Renal Stromal Tumors: Prevalence in Metanephric Stromal Tumors. Human Pathology |